Atomo Diagnostics Limited (ASX:AT1) Completes $3.1M Capital Raise and Board Restructure
Atomo Diagnostics Limited (ASX:AT1) completes a $3.1 million capital raise and announces a board restructure to enhance operational efficiency and drive growth.
Atomo Diagnostics Limited (ASX:AT1) completes a $3.1 million capital raise and announces a board restructure to enhance operational efficiency and drive growth.
Sandon Capital Investments Limited (ASX:SNC) declares a fully franked June quarter dividend of 1.4c per share, offering a 7.2% yield amid strong FY2025 returns.
PWR (ASX:PWH) announces the temporary leave of its Managing Director and the appointment of Matthew Bryson as Acting CEO.
Evion Group NL (ASX:EVG) secures community support for the Maniry Graphite Mine and advances toward final environmental approvals.
AusQuest Limited (ASX:AQD) announces Stage 2 Reverse Circulation drilling at its Cangallo project in Peru, with results expected in July 2025.
Proteomics International (ASX:PIQ) launches PromarkerD test in Australia and secures $4.5m funding to support its precision diagnostics growth.
Resolute Mining Limited (ASX:RSG) reports a strong Q1 2025 with increased net cash, robust operations, and promising exploration results.
Generation Development Group (ASX:GDG) reports robust March quarter growth, solidifying market leadership and achieving ASX 200 status.
Lumos Diagnostics (ASX:LDX) expands Medicare reimbursement for FebriDx to over 55% of US coverage, enhancing market access.
Global Masters Fund Limited (ASX:GFL) reports stable conversion price and a 13.54% LTV ratio in its quarterly Convertible Notes report.